S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Actualizaciones en tiempo real para Amniotics AB (publ) [AMNI.ST]

Bolsa: STO Sector: Healthcare Industria: Biotechnology
Última actualización3 may 2024 @ 11:14

2.63% SEK 0.00390

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:14):

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease...

Stats
Volumen de hoy 299 948
Volumen promedio 23.75M
Capitalización de mercado 10.57M
EPS SEK-0.00938 ( 2023-11-27 )
Próxima fecha de ganancias ( SEK0 ) 2024-05-21
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.0300
ATR14 SEK0 (0.00%)

Amniotics AB (publ) Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amniotics AB (publ) Finanzas

Annual 2023
Ingresos: SEK0
Beneficio Bruto: SEK-2.30M (0.00 %)
EPS: SEK-0.0676
FY 2023
Ingresos: SEK0
Beneficio Bruto: SEK-2.30M (0.00 %)
EPS: SEK-0.0676
FY 2022
Ingresos: SEK0
Beneficio Bruto: SEK-1.79M (0.00 %)
EPS: SEK-0.300
FY 2021
Ingresos: SEK0.00
Beneficio Bruto: SEK0.00 (0.00 %)
EPS: SEK-3.34

Financial Reports:

No articles found.

Amniotics AB (publ)

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico